Patents by Inventor Alban Sidhu

Alban Sidhu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of cdc phosphatases
    Patent number: 8017637
    Abstract: A subject of the present invention is novel compounds comprising 2 or 3 benzothiazole-4,7-dione- or benzooxazole-4,7-dione-type units, which inhibit the cdc25 phosphatases, in particular cdc25-C phosphatase. These compounds can in particular be used in the treatment of cancer.
    Type: Grant
    Filed: December 16, 2005
    Date of Patent: September 13, 2011
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Marie-Odile Galcera-Contour, Dennis Bigg, Grégoire Prevost, Alban Sidhu
  • 4,7-Dioxobenzothiazole-2-Carboxamide Derivatives, Their Preparation And Their Therapeutic Uses
    Publication number: 20100317658
    Abstract: A subject of the present invention is 4,7-dioxobenzothiazole-2-carboxamide derivatives, which inhibit the cdc25 phosphatases, in particular cdc25-C phosphatase. These compounds can in particular be used in the treatment of cancer.
    Type: Application
    Filed: August 3, 2010
    Publication date: December 16, 2010
    Applicant: Ipsen Pharma S.A.S.
    Inventors: Marie-Odile Galcera-Contour, Grégoire Prevost, Alban Sidhu
  • 4,7-dioxobenzothiazole-2-carboxamide derivatives, their preparation and their therapeutic uses
    Patent number: 7795284
    Abstract: A subject of the present invention is 4,7-dioxobenzothiazole-2-carboxamide derivatives, which inhibit the cdc25 phosphatases, in particular cdc25-C phosphatase. These compounds can in particular be used in the treatment of cancer.
    Type: Grant
    Filed: November 7, 2005
    Date of Patent: September 14, 2010
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Marie-Odile Galcera-Contour, Grégoire Prevost, Alban Sidhu
  • INHIBITORS OF CDC PHOSPHATASES
    Publication number: 20090275624
    Abstract: A subject of the present invention is novel compounds comprising 2 or 3 benzothiazole-4,7-dione- or benzooxazole-4,7-dione-type units, which inhibit the cdc25 phosphatases, in particular cdc25-C phosphatase. These compounds can in particular be used in the treatment of cancer.
    Type: Application
    Filed: December 16, 2005
    Publication date: November 5, 2009
    Applicant: Societe de Conseils de Recherches et D'Applications Scientifiques (S.C.R.A.S.)
    Inventors: Marie-Odile Galcera-Contour, Dennis Bigg, Grégoire Prevost, Alban Sidhu
  • 4, 7-Dioxobenzothiazole-2-Carboxamide Derivatives, Their Preparation and Their Therapeutic Uses
    Publication number: 20070244186
    Abstract: A subject of the present invention is 4,7-dioxobenzothiazole-2-carboxamide derivatives, which inhibit the cdc25 phosphatases, in particular cdc25-C phosphatase. These compounds can in particular be used in the treatment of cancer.
    Type: Application
    Filed: November 7, 2005
    Publication date: October 18, 2007
    Inventors: Marie-Odile Galcera-Contour, Gregoire Prevost, Alban Sidhu
  • 5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
    Publication number: 20050154039
    Abstract: The invention concerns novel 5-sulphanyl-4<I>H</I>-1,2,4-triazole derivatives of formula (1), wherein: R1, R2 and R3 represent variable groups and the methods for preparing them by liquid-phase parallel synthesis processes. Said product exhibit good affinity for certain sub-types of somatostatin receptors; they are particularly useful for treating pathological conditions or diseases wherein one (or more) somatostatin receptors is (are) involved. The invention also concerns pharmaceutical compositions containing said products and their use for preparing a medicine.
    Type: Application
    Filed: November 27, 2002
    Publication date: July 14, 2005
    Inventors: Marie-Odile Glacera Contour, Alban Sidhu, Pierre Roubert, Christophe Thurieau